Approval · Notice of Compliance 16437 · 2014
ESBRIET: Notice of Compliance 16437
Issued December 12, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16437
- Date
- December 12, 2014
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Therapeutic class
- Anti-fibrotic, anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESBRIET | 02393751 | Cancelled Post Market |
Medicinal ingredients
- PIRFENIDONE 267 MG per CAP